Veracyte announced that its Prosigna Breast Risk of Recurrence test has received Medicare coverage through Palmetto GBA’s MolDX program, effective August 19, 2026. This reimbursement enables eligible postmenopausal women with early-stage ER+ breast cancer to access the test, which helps guide personalized treatment decisions by assessing tumor biology and recurrence risk. The milestone supports broader adoption of Prosigna in the U.S. and aims to help patients and doctors decide on chemotherapy benefits. Veracyte also offers financial assistance for uninsured or underinsured patients to improve access.
Veracyte's Prosigna Breast Risk of Recurrence test news coincides with a Health-sector market where 96 of 150 US stocks rose and 43 fell on Pluang. Among notable movers as of Oct 16, 2026 19:42 WIB, Takeda Pharmaceutical Company Limited shares rose 1.80% with 100% buy order activity and a typical hold time of 3 days, while Maravai LifeSciences Holdings and Mesoblast Limited shares declined by 2.26% and 2.08% respectively.
Whole Lotta Dank, a Canadian cannabis brand platform, has launched its first brand, Dank Pack, debuting with Blueberry BBL available across Alberta. The company is expanding its portfolio with over 20 SKUs under regulatory review and is actively seek...
Nasdaq announced that trading in CN Healthy Food Tech Group Corp.'s common stock and warrants will resume on October 19, 2026, after being halted since October 1, 2025. The resumption marks the end of a year-long trading suspension, allowing investor...
David Solomon, CEO of Goldman Sachs, has been appointed as the new chair of The Business Council, taking over from Brian Cornell, Executive Chair of Target Corporation. This leadership change comes at a critical time as the Council addresses challeng...
The global pharmaceutical market is projected to grow from USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, expanding at a CAGR of 6.15%. Growth is fueled by advances in biologics, AI-driven drug discovery, specialty drugs, and manufacturing i...
SEDA Experts LLC has appointed Noor Ul Islam as Managing Director, enhancing its capabilities in risk management and securities practices. With nearly 30 years of experience at major financial institutions like Citibank and Barclays, Islam brings dee...
